📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Lysogene

1.1 - Company Overview

Lysogene Logo

Lysogene

Headquarter: France
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of basic research and clinical development of gene therapy for neurodegenerative disorders, developing AAV vectors, with a mission to improve the health of patients with incurable, life-threatening conditions.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Lysogene

Amyris Logo

Amyris

HQ: United States Website
  • Description: Provider of biotech chemical products made via advanced sugarcane-derived fermentation. Portfolio includes Neossance Squalane for cosmetics and skincare moisturization and barrier repair; Artemisinic Acid used in antimalarial treatments; Biosilica from sugarcane ashes for cosmetics; Neossance Hemisqualane as a plant-based silicone alternative; Biofene renewable specialty chemical building block; RealSweet Reb M zero-calorie sweetener.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Amyris company profile →
EpiBiome Logo

EpiBiome

HQ: United States Website
  • Description: Provider of precision microbiome engineering focused on developing alternatives to small-molecule antibiotics for use in healthcare, veterinary, and agriculture industries to address antibiotic resistance.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full EpiBiome company profile →
GenEdit Logo

GenEdit

HQ: United States Website
  • Description: Provider of a proprietary non-viral, non-lipid polymer nanoparticle platform (NanoGalaxy) for safe, efficient delivery of genetic medicine payloads—including nucleic acids, therapeutic proteins, and CRISPR/Cas9—to specific tissues. Offers tissue selectivity, payload flexibility, ability to redose without immune response, and scalable manufacturing with batch-to-batch purity and long-term stability that reduces cold-chain logistics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full GenEdit company profile →
Loop Genomics Logo

Loop Genomics

HQ: United States Website
  • Description: Provider of platform technology for long-read DNA sequencing that transforms short-read DNA sequencers into high-throughput, long-read, single-molecule systems, delivering phased sequencing solutions for research and clinical applications. Solutions include the AVITI System (high accuracy, low run costs, dual flow cells), Teton CytoProfiling with AVITI24, and Avidity Base Chemistry.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Loop Genomics company profile →
GenSight Biologics Logo

GenSight Biologics

HQ: France Website
  • Description: Provider of gene therapy-based treatments for retinal degenerative diseases. Develops candidates such as GS010 (lenadogene nolparvovec) for Leber Hereditary Optic Neuropathy (LHON) and GS030, an optogenetics-based therapy in Phase I/II trials, leveraging mitochondrial targeting sequence (MTS) technology and optogenetics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full GenSight Biologics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Lysogene

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Lysogene

2.2 - Growth funds investing in similar companies to Lysogene

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Lysogene

4.2 - Public trading comparable groups for Lysogene

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Lysogene

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Lysogene

What does Lysogene do?

Lysogene is a provider of basic research and clinical development of gene therapy for neurodegenerative disorders, developing AAV vectors, with a mission to improve the health of patients with incurable, life-threatening conditions.

Who are Lysogene's competitors?

Lysogene's competitors and similar companies include Amyris, EpiBiome, GenEdit, Loop Genomics, and GenSight Biologics.

Where is Lysogene headquartered?

Lysogene is headquartered in France.

How many employees does Lysogene have?

Lysogene has 1,000 employees 🔒.

When was Lysogene founded?

Lysogene was founded in 2010 🔒.

What sector and industry vertical is Lysogene in?

Lysogene is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Lysogene

Who are the top strategic acquirers in Lysogene's sector and industry

Top strategic M&A buyers and acquirers in Lysogene's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Lysogene?

Top strategic M&A buyers groups and sectors for Lysogene include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Lysogene's sector and industry vertical

Which are the top PE firms investing in Lysogene's sector and industry vertical?

Top PE firms investing in Lysogene's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Lysogene's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Lysogene's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Lysogene's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Lysogene include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Lysogene's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Lysogene?

The key public trading comparables and valuation benchmarks for Lysogene include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Lysogene for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Lysogene with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Lysogene's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Lysogene with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Lysogene's' sector and industry vertical?

Access recent funding rounds and capital raises in Lysogene's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Lysogene